SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-012224
Filing Date
2021-11-15
Accepted
2021-11-15 16:20:39
Documents
16
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 24351
2 ADDITIONAL EXHIBITS drma_ex991.htm EX-99.1 59056
3 IMAGE drma_ex991img1.jpg GRAPHIC 4925
  Complete submission text file 0001654954-21-012224.txt   237861

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20211115.xsd EX-101.SCH 5819
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20211115_cal.xml EX-101.CAL 890
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20211115_def.xml EX-101.DEF 3943
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20211115_lab.xml EX-101.LAB 16328
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20211115_pre.xml EX-101.PRE 12118
9 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4697
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 211411012
SIC: 2834 Pharmaceutical Preparations